Clinical trials recruiting for Heterozygous Familial Hypercholesterolemia
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Lerodalcibep | 1 |
| VERVE-102 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Alabama | 1 |
| California | 1 |
| Florida | 1 |
| Indiana | 1 |
| North Carolina | 1 |
| Pennsylvania | 1 |
| Texas | 1 |
| Washington | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
- A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
- Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia
Related conditions
Trials recruiting for Heterozygous Familial Hypercholesterolemia often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Heterozygous Familial Hypercholesterolemia trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.